retatrutide parkinson's disease trial nct approval: FDA status, clinical results, and when it could be available Parkinson's drug therapies in the

Structured monitoring helps preserve muscle and metabolic rate during fat loss

Potential Negative Effects on Mental Health While the potential benefits are encouraging, its crucial to acknowledge the potential negative impacts of GLP-1 inhibitors on mental health: Increased Anxiety and Agitation: Paradoxically, while some studies suggest anxiety reduction, others have reported instances of increased anxiety, restlessness, and agitation in individuals taking GLP-1 agonists

in financing Hanmi starts phase 3 diabetes trial for GLP-1 drug ahead of obesity launch Kim Ji-hye [email protected]

Raufman JP, Singh L, Singh G, and Eng J

At the 12th Aging Research and Drug Discovery meeting (ARDD2025) in Copenhagen, the narrative surrounding GLP-1 receptor agonists shifted profoundly